Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366351508> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W4366351508 abstract "The association between atrial fibrillation (AF) and the prognosis of acute ischaemic stroke (AIS) remains controversial; whether the recombinant tissue plasminogen activator dose influences this association remains poorly understood.Patients who had an AIS were enrolled from eight stroke centres in China. According to the recombinant tissue plasminogen activator dose, patients treated with intravenous recombinant tissue plasminogen activator within 4.5 hours after symptom onset were divided into a low-dose group (recombinant tissue plasminogen activator <0.85 mg/kg) and a standard-dose group (recombinant tissue plasminogen activator ≥0.85 mg/kg). Patients who had an AIS in the low-dose group and the standard dose group were divided into whether or not they had AF. The main outcomes were major disability (modified Rankin scale (mRS) score 3-5), mortality and vascular events occurring within 3 months.The study included 630 patients who received recombinant tissue plasminogen activator after AIS, including 391 males and 239 females, with a mean age of 65.8 years. Of these patients, 305 (48.4%) received low-dose recombinant tissue plasminogen activator and 325 (51.6%) received standard dose recombinant tissue plasminogen activator. The recombinant tissue plasminogen activator dose significantly influenced the association between AF and death or major disability (p-interaction=0.036). After multivariate adjustment, AF was associated with an increased risk of death or major disability (OR 2.90, 95% CI 1.47 to 5.72, p=0.002), major disability (OR 1.93, 95% CI 1.04 to 3.59, p=0.038) and vascular events (HR 5.01, 95% CI 2.25 to 11.14, p<0.001) within 3 months in patients with standard-dose recombinant tissue plasminogen activator. No significant association was found between AF and any clinical outcome in patients with low-dose recombinant tissue plasminogen activator (all p>0.05). With AF, the mRS score distribution showed a significantly worse shift in patients with standard-dose recombinant tissue plasminogen activator (p=0.016) than in those with low-dose recombinant tissue plasminogen activator (p=0.874).AF may be a strong predictor of poor prognosis in patients who had an AIS receiving standard-dose recombinant tissue plasminogen activator, suggesting that low-dose recombinant tissue plasminogen activator should be administered to patients who had a stroke with AF to improve their prognosis." @default.
- W4366351508 created "2023-04-21" @default.
- W4366351508 creator A5021162676 @default.
- W4366351508 creator A5035890146 @default.
- W4366351508 creator A5036432582 @default.
- W4366351508 creator A5046784859 @default.
- W4366351508 creator A5046823210 @default.
- W4366351508 creator A5047689236 @default.
- W4366351508 creator A5054464310 @default.
- W4366351508 creator A5055952341 @default.
- W4366351508 creator A5071957217 @default.
- W4366351508 creator A5073239054 @default.
- W4366351508 creator A5078164215 @default.
- W4366351508 date "2022-06-24" @default.
- W4366351508 modified "2023-10-16" @default.
- W4366351508 title "Effect of the interaction between atrial fibrillation and rt-PA dose on the prognosis of acute ischaemic stroke with intravenous thrombolysis." @default.
- W4366351508 doi "https://doi.org/10.1136/postmj/postgradmedj-2022-141710" @default.
- W4366351508 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37073538" @default.
- W4366351508 hasPublicationYear "2022" @default.
- W4366351508 type Work @default.
- W4366351508 citedByCount "0" @default.
- W4366351508 crossrefType "journal-article" @default.
- W4366351508 hasAuthorship W4366351508A5021162676 @default.
- W4366351508 hasAuthorship W4366351508A5035890146 @default.
- W4366351508 hasAuthorship W4366351508A5036432582 @default.
- W4366351508 hasAuthorship W4366351508A5046784859 @default.
- W4366351508 hasAuthorship W4366351508A5046823210 @default.
- W4366351508 hasAuthorship W4366351508A5047689236 @default.
- W4366351508 hasAuthorship W4366351508A5054464310 @default.
- W4366351508 hasAuthorship W4366351508A5055952341 @default.
- W4366351508 hasAuthorship W4366351508A5071957217 @default.
- W4366351508 hasAuthorship W4366351508A5073239054 @default.
- W4366351508 hasAuthorship W4366351508A5078164215 @default.
- W4366351508 hasConcept C104317684 @default.
- W4366351508 hasConcept C126322002 @default.
- W4366351508 hasConcept C127413603 @default.
- W4366351508 hasConcept C141071460 @default.
- W4366351508 hasConcept C164705383 @default.
- W4366351508 hasConcept C185592680 @default.
- W4366351508 hasConcept C2776572282 @default.
- W4366351508 hasConcept C2779161974 @default.
- W4366351508 hasConcept C2779581417 @default.
- W4366351508 hasConcept C2779679481 @default.
- W4366351508 hasConcept C2780645631 @default.
- W4366351508 hasConcept C2780931571 @default.
- W4366351508 hasConcept C2909373784 @default.
- W4366351508 hasConcept C2911092318 @default.
- W4366351508 hasConcept C3020199598 @default.
- W4366351508 hasConcept C40767141 @default.
- W4366351508 hasConcept C500558357 @default.
- W4366351508 hasConcept C541997718 @default.
- W4366351508 hasConcept C55493867 @default.
- W4366351508 hasConcept C71924100 @default.
- W4366351508 hasConcept C78519656 @default.
- W4366351508 hasConcept C90924648 @default.
- W4366351508 hasConceptScore W4366351508C104317684 @default.
- W4366351508 hasConceptScore W4366351508C126322002 @default.
- W4366351508 hasConceptScore W4366351508C127413603 @default.
- W4366351508 hasConceptScore W4366351508C141071460 @default.
- W4366351508 hasConceptScore W4366351508C164705383 @default.
- W4366351508 hasConceptScore W4366351508C185592680 @default.
- W4366351508 hasConceptScore W4366351508C2776572282 @default.
- W4366351508 hasConceptScore W4366351508C2779161974 @default.
- W4366351508 hasConceptScore W4366351508C2779581417 @default.
- W4366351508 hasConceptScore W4366351508C2779679481 @default.
- W4366351508 hasConceptScore W4366351508C2780645631 @default.
- W4366351508 hasConceptScore W4366351508C2780931571 @default.
- W4366351508 hasConceptScore W4366351508C2909373784 @default.
- W4366351508 hasConceptScore W4366351508C2911092318 @default.
- W4366351508 hasConceptScore W4366351508C3020199598 @default.
- W4366351508 hasConceptScore W4366351508C40767141 @default.
- W4366351508 hasConceptScore W4366351508C500558357 @default.
- W4366351508 hasConceptScore W4366351508C541997718 @default.
- W4366351508 hasConceptScore W4366351508C55493867 @default.
- W4366351508 hasConceptScore W4366351508C71924100 @default.
- W4366351508 hasConceptScore W4366351508C78519656 @default.
- W4366351508 hasConceptScore W4366351508C90924648 @default.
- W4366351508 hasLocation W43663515081 @default.
- W4366351508 hasOpenAccess W4366351508 @default.
- W4366351508 hasPrimaryLocation W43663515081 @default.
- W4366351508 hasRelatedWork W186772659 @default.
- W4366351508 hasRelatedWork W1897338715 @default.
- W4366351508 hasRelatedWork W1993192912 @default.
- W4366351508 hasRelatedWork W2026830745 @default.
- W4366351508 hasRelatedWork W2087950998 @default.
- W4366351508 hasRelatedWork W2126793715 @default.
- W4366351508 hasRelatedWork W2372710020 @default.
- W4366351508 hasRelatedWork W2381891610 @default.
- W4366351508 hasRelatedWork W2419452379 @default.
- W4366351508 hasRelatedWork W4283366385 @default.
- W4366351508 isParatext "false" @default.
- W4366351508 isRetracted "false" @default.
- W4366351508 workType "article" @default.